Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01140282 · ClinicalTrials.gov registry record · NA
Exercise Program for Early Breast Cancer Survivors
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT01140282: Completed NA study, sponsored by University of Southern California.
NCT01140282 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01140282, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
Rationale: Exercise therapy may improve the quality of life of breast cancer survivors. Purpose: This randomized clinical trial studies exercise therapy and quality of life in postmenopausal early breast cancer survivors receiving aromatase inhibitor therapy.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- BEHAVIORAL exercise intervention
- PROCEDURE management of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2012-05-21 |
| Est. Completion | 2018-10-01 |
| Phase | NA |
What the finished NCT01140282 record still lists
NCT01140282 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.
NCT01140282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01140282 about?
NCT01140282 is a clinical study titled "Exercise Program for Early Breast Cancer Survivors". Rationale: Exercise therapy may improve the quality of life of breast cancer survivors. Purpose: This randomized clinical trial studies exercise therapy and quality of life in postmenopausal early breast cancer survivors receiving aromatase inhibitor therapy.
What is the current status of trial NCT01140282?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2012-05-21. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT01140282?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), exercise intervention (BEHAVIORAL), management of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT01140282?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01140282's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI